全文获取类型
收费全文 | 37582篇 |
免费 | 2152篇 |
国内免费 | 245篇 |
专业分类
耳鼻咽喉 | 281篇 |
儿科学 | 896篇 |
妇产科学 | 866篇 |
基础医学 | 4428篇 |
口腔科学 | 813篇 |
临床医学 | 2815篇 |
内科学 | 9124篇 |
皮肤病学 | 733篇 |
神经病学 | 3948篇 |
特种医学 | 1175篇 |
外国民族医学 | 1篇 |
外科学 | 5632篇 |
综合类 | 203篇 |
一般理论 | 12篇 |
预防医学 | 2052篇 |
眼科学 | 705篇 |
药学 | 2251篇 |
中国医学 | 92篇 |
肿瘤学 | 3952篇 |
出版年
2023年 | 203篇 |
2022年 | 213篇 |
2021年 | 1012篇 |
2020年 | 619篇 |
2019年 | 821篇 |
2018年 | 999篇 |
2017年 | 761篇 |
2016年 | 841篇 |
2015年 | 985篇 |
2014年 | 1378篇 |
2013年 | 1784篇 |
2012年 | 2643篇 |
2011年 | 2622篇 |
2010年 | 1608篇 |
2009年 | 1451篇 |
2008年 | 2331篇 |
2007年 | 2416篇 |
2006年 | 2247篇 |
2005年 | 2164篇 |
2004年 | 2177篇 |
2003年 | 1875篇 |
2002年 | 1872篇 |
2001年 | 698篇 |
2000年 | 565篇 |
1999年 | 553篇 |
1998年 | 411篇 |
1997年 | 340篇 |
1996年 | 319篇 |
1995年 | 294篇 |
1994年 | 218篇 |
1993年 | 212篇 |
1992年 | 348篇 |
1991年 | 302篇 |
1990年 | 295篇 |
1989年 | 276篇 |
1988年 | 233篇 |
1987年 | 191篇 |
1986年 | 203篇 |
1985年 | 180篇 |
1984年 | 173篇 |
1983年 | 124篇 |
1982年 | 92篇 |
1981年 | 87篇 |
1980年 | 55篇 |
1979年 | 72篇 |
1977年 | 63篇 |
1976年 | 52篇 |
1975年 | 48篇 |
1974年 | 54篇 |
1973年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 359 毫秒
1.
2.
3.
Cost‐Effectiveness and Cost‐Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study 下载免费PDF全文
Furio Zucco MD Roberta Ciampichini MSc Angelo Lavano MD Amedeo Costantini MD Marisa De Rose MD Paolo Poli MD Gianpaolo Fortini MD Laura Demartini MD Enrico De Simone MD Valentino Menardo MD Piero Cisotto MD Mario Meglio MD Luciana Scalone PhD Lorenzo G. Mantovani DSc 《Neuromodulation》2015,18(4):266-276
4.
Susanna Zanutto Chiara Maura Ciniselli Antonino Belfiore Mara Lecchi Enzo Masci Gabriele Delconte Massimo Primignani Giulia Tosetti Marco Dal Fante Linda Fazzini Aldo Airoldi Marcello Vangeli Francesca Turpini Giovanni Giuseppe Rubis Passoni Paolo Viaggi Monica Arena Roberta Ilaria Olimpia Motta Anna Maria Cantù Cristiano Crosta Giuseppe De Roberto Francesca Iannuzzi Andrea Cassinotti Valentina Dall'Olio Laura Tizzoni Gabriella Sozzi Emanuele Meroni Luigi Bisanti Marco Alessandro Pierotti Paolo Verderio Manuela Gariboldi 《International journal of cancer. Journal international du cancer》2020,146(4):1164-1173
Colorectal cancer (CRC) screening programs help diagnose cancer precursors and early cancers and help reduce CRC mortality. However, currently recommended tests, the fecal immunochemical test (FIT) and colonoscopy, have low uptake. There is therefore a pressing need for screening strategies that are minimally invasive and consequently more acceptable to patients, most likely blood based, to increase early CRC identification. MicroRNAs (miRNAs) released from cancer cells are detectable in plasma in a remarkably stable form, making them ideal cancer biomarkers. Using plasma samples from FIT-positive (FIT+) subjects in an Italian CRC screening program, we aimed to identify plasma circulating miRNAs that detect early CRC. miRNAs were initially investigated by quantitative real-time PCR in plasma from 60 FIT+ subjects undergoing colonoscopy at Fondazione IRCCS Istituto Nazionale dei Tumori, then tested on an internal validation cohort (IVC, 201 cases) and finally in a large multicenter prospective series (external validation cohort [EVC], 1121 cases). For each endoscopic lesion (low-grade adenoma [LgA], high-grade adenoma [HgA], cancer lesion [CL]), specific signatures were identified in the IVC and confirmed on the EVC. A two-miRNA-based signature for CL and six-miRNA signatures for LgA and HgA were selected. In a multivariate analysis including sex and age at blood collection, the areas under the receiver operating characteristic curve (95% confidence interval) of the signatures were 0.644 (0.607–0.682), 0.670 (0.626–0.714) and 0.682 (0.580–0.785) for LgA, HgA and CL, respectively. A miRNA-based test could be introduced into the FIT+ workflow of CRC screening programs so as to schedule colonoscopies only for subjects likely to benefit most. 相似文献
5.
La Rosa Mauricio Omere Chasey Redfern Tiffany Abdelwahab Mahmoud Spencer Nicholas Villarreal Josephine Olson Gayle Saade George R. Saad Antonio F. 《Archives of gynecology and obstetrics》2020,301(1):69-73
Archives of Gynecology and Obstetrics - The objective of this study was to determine if high-dose antibiotic prophylaxis with cefazolin decreases the risk of surgical site infection (SSI) after a... 相似文献
6.
7.
Alessia Scarselli Silvia Di Cesare Claudia Capponi Simona Cascioli Maria L. Romiti Gigliola Di Matteo Alessandra Simonetti Paolo Palma Andrea Finocchi Barbarella Lucarelli Rita M. Pinto Ippolita Rana Giuseppe Palumbo Maurizio Caniglia Paolo Rossi Rita Carsetti Caterina Cancrini Alessandro Aiuti 《Journal of clinical immunology》2015,35(4):373-383
8.
9.
10.
Raffaella Marcheselli Alessia Bari Tamar Tadmor Luigi Marcheselli Maria Christina Cox Robel Papotti Angela Ferrari Luca Baldini Paolo Gobbi Ilana Levy Giuseppe Pugliese Massimo Federico Aaron Polliack Samantha Pozzi Stefano Sacchi 《Hematological oncology》2020,38(4):439-445
The main purpose of this study was to assess whether it is possible to improve the prognostic impact of international prognostic index (IPI) score by combining it with peripheral blood counts. Thus, we evaluated the prognostic power of lymphocyte, neutrophil, and monocyte counts in 520 patients with diffuse large B cell lymphoma treated with R-CHOP, confirming that these parameters have a strong impact on overall survival (OS). Using revised IPI (R-IPI), 44% of patients were categorized as poor-risk and showed an OS at 5 years of 46%. As OS at 5 years of the 520 patients is 67%, it is clearly evident that R-IPI tends to overestimate the proportion of patients with poor prognosis. Accordingly, in an attempt to improve the discriminating power of R-IPI, we evaluated and compared three different scores by combining the neutrophil lymphocyte ratio (NLR) and absolute monocyte count (AMC) with the following values: (a) IPI score 3-5, (b) age > 60 years and performance status, (c) age ≥ 65 years and LDH > ULN. The three indexes studied, had a similar 5 years OS for the high-risk group (46%-52%), but the proportion of patients classified as poor-risk were 37%, 20%, and 32%, respectively, which are lower than 44% identified with R-IPI. Thus, while R-IPI overestimates the number of high-risk patients, after applying our models, it is possible to recognize patients who are truly at high-risk. Of the three scores, the most accurate appears to be that based on NLR, AMC, LDH > ULN and age ≥ 65 years, which identifies 32% of high-risk patients, correlating well with what is seen in clinical practice. 相似文献